Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma

Clinical trial NCT01530594 · COMPLETED

Trial details

NCT number: NCT01530594
Sponsor: King Faisal Specialist Hospital & Research Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2009-01-01
Primary completion: 2013-01-01
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.